Tenax Therapeutics (TENX) News
NASDAQ: TENXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
TENX news summary
We found 16 recent headlines mentioning Tenax Therapeutics (TENX): 2 in the past week and 16 in the past 30 days, most often from PR Newswire, Nasdaq. TENX is making an outsized move today, down 10.07% at $1.25, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "TENX Investors Have Rights - If You Lost Money Investing in Tenax Therapeutics, Inc. Contact Robbins LLP for Information About Recovering Your Losses", was published by PR Newswire on Nov 16, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Tenax Therapeutics headlines
- TENX Investors Have Rights - If You Lost Money Investing in Tenax Therapeutics, Inc. Contact Robbins LLP for Information About Recovering Your LossesSAN DIEGO, Nov. 16, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise…PR Newswire
- INVESTOR REMINDER: Berger Montague Notifies Tenax Therapeutics, Inc. (NASDAQ: TENX) Investors of a Class Action Lawsuit and DeadlinePHILADELPHIA, Nov. 16, 2026 /PRNewswire/ -- Berger Montague, a leading national plaintiffs' law firm, announces a class action lawsuit against Tenax Therapeutics, Inc. (NASDAQ: TENX) ("Tenax" or the…PR Newswire
- Pomerantz Law Firm Announces the Filing of a Class Action Against Tenax Therapeutics, Inc. and Certain Officers - TENXNEW YORK, Nov. 12, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Tenax Therapeutics, Inc. ("Tenax" or the "Company") (NASDAQ: TENX) and certain…PR Newswire
- Tenax Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - TENXNEW YORK, Nov. 9, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Tenax Therapeutics, Inc. ("Tenax" or "the Company") (NASDAQ: TENX) for violations of…PR Newswire
- INVESTOR DEADLINE: Tenax Therapeutics, Inc. (TENX) Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 28, 2026 DeadlineSAN DIEGO, Nov. 9, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tenax Therapeutics, Inc. (NASDAQ: TENX) securities between November…PR Newswire
- TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS LawLOS ANGELES, Nov. 9, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of…PR Newswire
- TENX Investors Have Opportunity to Lead Tenax Therapeutics, Inc. Securities Fraud LawsuitNEW YORK, Nov. 7, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tenax Therapeutics, Inc. (NASDAQ: TENX) between November 13, 2023…PR Newswire
- Tenax Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - TENXNEW YORK, Nov. 6, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Tenax Therapeutics, Inc. ("Tenax" or "the Company") (NASDAQ: TENX) for violations of…PR Newswire
- TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS LawLOS ANGELES, Nov. 6, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of…PR Newswire
- Tenax Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate UpdateTenax Therapeutics, Inc. reported its financial results for the third quarter ended September 30, 2026, with cash and cash equivalents of $113.7 million as of September 30, 2026. The company reported…Nasdaq
- TENX Investors Have Opportunity to Lead Tenax Therapeutics, Inc. Securities Fraud LawsuitNEW YORK, Nov. 2, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Tenax Therapeutics, Inc.…PR Newswire
- TENX INVESTOR ALERT: Tenax Therapeutics, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 28, 2026 DeadlineSAN DIEGO, Nov. 1, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tenax Therapeutics, Inc. (NASDAQ: TENX) securities between November…PR Newswire
- SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Tenax Therapeutics, Inc. (NASDAQ: TENX) -- Investors Who Suffered Losses Are Encouraged to Contact the Firm.Lead Plaintiff Deadline: December 28, 2026. Investors who purchased (NASDAQ: TENX) securities between November 13, 2023 and August 7, 2026 may be eligible to recover losses. NEW YORK, Oct. 30, 2026…PR Newswire
- ATTENTION NASDAQ: TENX INVESTORS: Contact Berger Montague About a Tenax Therapeutics, Inc. Class Action LawsuitPHILADELPHIA, Oct. 30, 2026 /PRNewswire/ -- Berger Montague, a leading national plaintiffs' law firm, announces a class action lawsuit against Tenax Therapeutics, Inc. (NASDAQ: TENX) ("Tenax" or the…PR Newswire
- TENX Investors Have Opportunity to Lead Tenax Therapeutics, Inc. Securities Fraud LawsuitNEW YORK, Oct. 28, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Tenax Therapeutics, Inc.…PR Newswire
- TENX Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Tenax Therapeutics, Inc.SAN DIEGO, Oct. 27, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise…PR Newswire